MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
2.190
-0.018 (-0.82%)
Jul 3, 2025, 1:00 PM EDT - Market closed
MDxHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 94.51 | 90.05 | 70.19 | 37.05 | 22.24 | 18.46 | Upgrade
| |
Revenue Growth (YoY) | 25.46% | 28.29% | 89.43% | 66.62% | 20.47% | 56.64% | Upgrade
|
Cost of Revenue | 35.93 | 34.91 | 26.26 | 17.84 | 11.68 | 10.42 | Upgrade
|
Gross Profit | 58.58 | 55.14 | 43.93 | 19.22 | 10.56 | 8.04 | Upgrade
|
Selling, General & Admin | 64.06 | 63.78 | 59.93 | 49.01 | 31.37 | 30.74 | Upgrade
|
Research & Development | 10.89 | 10.55 | 6.38 | 5.45 | 5.59 | 4.27 | Upgrade
|
Other Operating Expenses | 1.24 | 0.62 | 0.46 | 0.07 | -0.12 | -0.12 | Upgrade
|
Operating Expenses | 81.29 | 79.86 | 71.26 | 57.71 | 38.45 | 34.89 | Upgrade
|
Operating Income | -22.71 | -24.72 | -27.33 | -38.49 | -27.88 | -26.85 | Upgrade
|
Interest Expense | -9.53 | -7.63 | -5.58 | -2.64 | -1.88 | -1.35 | Upgrade
|
Interest & Investment Income | 0.4 | 1.08 | 1.09 | 0.13 | 0.01 | 0 | Upgrade
|
Other Non Operating Income (Expenses) | 0.62 | 0.62 | -2.12 | -0.19 | -0.1 | -0.19 | Upgrade
|
EBT Excluding Unusual Items | -31.22 | -30.66 | -33.95 | -41.19 | -29.85 | -28.39 | Upgrade
|
Asset Writedown | - | - | - | -0.04 | - | -0.27 | Upgrade
|
Other Unusual Items | -7.03 | -7.03 | -9.15 | -2.81 | 0.85 | - | Upgrade
|
Pretax Income | -38.25 | -37.69 | -43.1 | -44.04 | -29 | -28.66 | Upgrade
|
Income Tax Expense | 0.52 | 0.38 | 0 | - | - | - | Upgrade
|
Net Income | -38.77 | -38.07 | -43.1 | -44.04 | -29 | -28.66 | Upgrade
|
Net Income to Common | -38.77 | -38.07 | -43.1 | -44.04 | -29 | -28.66 | Upgrade
|
Shares Outstanding (Basic) | 38 | 33 | 26 | 16 | 12 | 8 | Upgrade
|
Shares Outstanding (Diluted) | 38 | 33 | 26 | 16 | 12 | 8 | Upgrade
|
Shares Change (YoY) | 39.86% | 26.82% | 63.31% | 30.12% | 46.56% | 32.95% | Upgrade
|
EPS (Basic) | -1.02 | -1.16 | -1.66 | -2.78 | -2.38 | -3.44 | Upgrade
|
EPS (Diluted) | -1.02 | -1.16 | -1.66 | -2.78 | -2.38 | -3.44 | Upgrade
|
Free Cash Flow | -17.09 | -19.72 | -24.24 | -36.91 | -23.44 | -20.78 | Upgrade
|
Free Cash Flow Per Share | -0.45 | -0.60 | -0.94 | -2.33 | -1.92 | -2.50 | Upgrade
|
Gross Margin | 61.99% | 61.23% | 62.58% | 51.87% | 47.50% | 43.58% | Upgrade
|
Operating Margin | -24.03% | -27.45% | -38.93% | -103.87% | -125.37% | -145.45% | Upgrade
|
Profit Margin | -41.02% | -42.28% | -61.40% | -118.86% | -130.41% | -155.27% | Upgrade
|
Free Cash Flow Margin | -18.08% | -21.90% | -34.54% | -99.60% | -105.42% | -112.57% | Upgrade
|
EBITDA | -16.59 | -18.96 | -22.18 | -33.58 | -24.85 | -24.29 | Upgrade
|
EBITDA Margin | -17.56% | -21.05% | -31.59% | -90.62% | -111.72% | -131.58% | Upgrade
|
D&A For EBITDA | 6.11 | 5.77 | 5.15 | 4.91 | 3.04 | 2.56 | Upgrade
|
EBIT | -22.71 | -24.72 | -27.33 | -38.49 | -27.88 | -26.85 | Upgrade
|
EBIT Margin | -24.03% | -27.45% | -38.93% | -103.87% | -125.37% | -145.45% | Upgrade
|
Revenue as Reported | - | - | - | - | 22.24 | 18.46 | Upgrade
|
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.